Martha R. Kelso, RN, HBOT, discusses how a recent study on the efficacy and cost-effectiveness of dHACM allografts is important for conveying to payers how important it is to cover advanced treatment modalities.
Martha R. Kelso, RN, HBOT, discusses how a recent study on the efficacy and cost-effectiveness of dHACM allografts is important for conveying to payers how important it is to cover advanced treatment modalities.